CMS

00867
9.7801.31% ( -0.130 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is 13.47, within the reasonable range, cheaper than 30.96% of the time in the past 5 years, and the industry ranks 17/53, the industry Median 6.96.

13.47xP/E
Stock priceHK$9.78Earnings per shareHK$0.73

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.96x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.96x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
01093HKCSPC PHARMA
10.63x128.56%HK$90.91B
02096HKSIMCERE PHARMA
14.90x31.93%HK$26.97B
00867HKCMS
13.47x41.06%HK$23.80B
01513HKLIVZON PHARMA
12.23x17.45%HK$22.18B
00512HKGRANDPHARMA
13.81x45.32%HK$15.32B
02005HKSSY GROUP
14.41x24.61%HK$7.31B
00460HKSIHUAN PHARM
19.94x322.94%HK$6.93B
03613HKTONGRENTANGCM
12.75x15.96%HK$4.60B
01666HKTONG REN TANG
10.92x21.20%HK$3.86B
00719HKSHANDONG XINHUA
13.19x--HK$3.51B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.